Get the Stockscreener App
7.68
6.82%
0.49
Teladoc Health Inc stock is traded at $7.68, with a volume of 6.03M.
It is up +6.82% in the last 24 hours and down -8.79% over the past month.
Teladoc Health Inc is engaged in virtual care, forging a new healthcare experience with improved convenience, outcomes, and value. Its mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems.
See More
Previous Close:
$7.19
Open:
$7.24
24h Volume:
6.03M
Relative Volume:
0.89
Market Cap:
$1.36B
Revenue:
$2.54B
Net Income/Loss:
$-207.36M
P/E Ratio:
-6.4538
EPS:
-1.19
Net Cash Flow:
$151.25M
1W Performance:
+2.13%
1M Performance:
-8.79%
6M Performance:
-33.28%
1Y Performance:
+8.02%
1-Day Range:
$7.22
$7.71
1-Week Range:
$7.06
$7.71
52-Week Range:
$6.35
$15.21
Teladoc Health Inc Stock (TDOC) Company Profile
Name
Teladoc Health Inc
Sector
Industry
Phone
(203) 635-2002
Address
155 E 44TH STREET, NEW YORK, NY
Compare TDOC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
7.68 | 1.32B | 2.54B | -207.36M | 151.25M | -1.19 |
|
VEEV
Veeva Systems Inc
|
290.86 | 46.10B | 2.86B | 780.66M | 1.19B | 4.72 |
|
TEM
Tempus Ai Inc
|
80.52 | 13.63B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
67.74 | 12.35B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
89.82 | 7.74B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.24 | 6.32B | 906.14M | -52.62M | 89.62M | -0.3621 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-25-25 | Initiated | Mizuho | Neutral |
| Nov-15-24 | Initiated | Goldman | Buy |
| Sep-17-24 | Reiterated | Jefferies | Hold |
| Feb-29-24 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-17-24 | Downgrade | DA Davidson | Buy → Neutral |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Apr-12-23 | Initiated | Stephens | Equal-Weight |
| Feb-23-23 | Upgrade | SVB Securities | Market Perform → Outperform |
| Oct-24-22 | Upgrade | Guggenheim | Sell → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-17-22 | Downgrade | Guggenheim | Neutral → Sell |
| Aug-12-22 | Initiated | DA Davidson | Buy |
| Aug-02-22 | Downgrade | Berenberg | Buy → Hold |
| Aug-02-22 | Downgrade | Cowen | Outperform → Market Perform |
| Jul-28-22 | Downgrade | Goldman | Buy → Neutral |
| Jul-28-22 | Downgrade | Needham | Buy → Hold |
| Jul-06-22 | Reiterated | BofA Securities | Neutral |
| May-05-22 | Downgrade | Argus | Buy → Hold |
| Apr-28-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-28-22 | Downgrade | Credit Suisse | Outperform → Neutral |
| Apr-28-22 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-28-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-28-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-28-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-28-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-03-22 | Upgrade | Argus | Hold → Buy |
| Feb-23-22 | Reiterated | BofA Securities | Neutral |
| Feb-23-22 | Reiterated | Craig Hallum | Hold |
| Feb-23-22 | Reiterated | Evercore ISI | In-line |
| Feb-23-22 | Reiterated | Goldman | Buy |
| Feb-23-22 | Reiterated | JP Morgan | Overweight |
| Feb-23-22 | Reiterated | KeyBanc Capital Markets | Overweight |
| Feb-23-22 | Reiterated | Needham | Buy |
| Feb-23-22 | Reiterated | Oppenheimer | Outperform |
| Feb-23-22 | Reiterated | Stifel | Hold |
| Feb-11-22 | Initiated | Goldman | Buy |
| Feb-08-22 | Reiterated | Piper Sandler | Overweight |
| Dec-02-21 | Resumed | Jefferies | Hold |
| Nov-22-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-28-21 | Reiterated | Barclays | Equal Weight |
| Oct-28-21 | Reiterated | BofA Securities | Neutral |
| Oct-28-21 | Reiterated | Canaccord Genuity | Buy |
| Oct-28-21 | Reiterated | Citigroup | Buy |
| Oct-28-21 | Reiterated | Craig Hallum | Hold |
| Oct-28-21 | Reiterated | Needham | Buy |
| Oct-28-21 | Reiterated | Oppenheimer | Outperform |
| Oct-28-21 | Reiterated | Piper Sandler | Overweight |
| Oct-28-21 | Reiterated | UBS | Neutral |
| Oct-19-21 | Initiated | Wells Fargo | Overweight |
| Aug-02-21 | Downgrade | Argus | Buy → Hold |
| Jul-28-21 | Downgrade | Deutsche Bank | Buy → Hold |
| May-28-21 | Initiated | Robert W. Baird | Neutral |
| Apr-15-21 | Initiated | Needham | Buy |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Dec-22-20 | Initiated | Evercore ISI | In-line |
| Dec-07-20 | Downgrade | Stephens | Overweight → Equal-Weight |
| Dec-04-20 | Initiated | Goldman | Neutral |
| Nov-13-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-22-20 | Initiated | DA Davidson | Buy |
| Sep-02-20 | Upgrade | Berenberg | Hold → Buy |
| Aug-17-20 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jul-14-20 | Initiated | Citigroup | Buy |
| Jul-13-20 | Initiated | Argus | Buy |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Apr-30-20 | Reiterated | KeyBanc Capital Markets | Overweight |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Mar-31-20 | Downgrade | Berenberg | Buy → Hold |
| Mar-25-20 | Downgrade | Craig Hallum | Buy → Hold |
| Mar-16-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-12-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-28-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-12-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-10-20 | Initiated | UBS | Neutral |
| Jan-09-20 | Downgrade | BofA/Merrill | Buy → Neutral |
View All
Teladoc Health Inc Stock (TDOC) Latest News
Momentum Traders Eye Teladoc Health Inc. for Quick Bounce2025 Breakouts & Breakdowns & Community Driven Trade Alerts - theviewers.co.kr
Healthcare Sector Rotation: Uncovering Undervalued Opportunities Amid Strategic M&A and Market Shifts - AInvest
GoodRx's Strategic Expansion of GLP-1 Access and Its Implications for Long-Term Growth - AInvest
Teladoc Health expands in Australia with Telecare acquisition - Yahoo Finance
Digital Health Market Demand, Growth, and Future Scope - openPR.com
Unexpected Trends Reshaping the Direct To Consumer Healthcare - openPR.com
Teladoc acquires Australian virtual care firm Telecare - Healthcare Dive
DocGo's Strategic Investor Engagement and Market Position in the Evolving Mobile Health Landscape - AInvest
Teladoc Health Inc. Approaches Psychological Resistance LevelEarnings Overview Summary & Fast Moving Trade Plans - 선데이타임즈
Key Deals: Gildan Activewear Acquires HanesBrands, Teladoc Health, and More - AInvest
Three Stocks With Strong Growth Potential: Pinterest, CoreWeave, and Teladoc Health - AInvest
Teladoc extends gains as Citron says it’s a “coiled spring” at current valuation - MSN
Key deals this week: Gildan Activewear, Western Union, Sapiens, Perplexity, Teladoc Health and more (WU:NYSE) - Seeking Alpha
Teladoc Expands Global Reach with Acquisition of Australian Telecare - AInvest
Teladoc Health Strengthens Virtual Care Capabilities through Telecare Acquisition - AInvest
Teladoc Health (TDOC) Stock Up 3.7% on Telecare DealMarket UpdateNews and Statistics - IndexBox
Why Teladoc (TDOC) Stock Is Trading Up Today - TradingView
Teladoc buys Australian virtual health provider Telecare - MSN
Teladoc stock in focus after Telecare buyout (TDOC:NYSE) - Seeking Alpha
Two Stocks Down 90%+ That Still Aren't Worth Buying: Teladoc and Tilray - AInvest
Teladoc Health Acquires Telecare, Expanding Access to - GlobeNewswire
Teladoc Health Acquires Telecare to Expand Virtual Care Access in Australia - AInvest
Teladoc Health Acquires Telecare, Expanding Access to Specialist and Allied Health Care for Australians in Public and Private Health - Benzinga
Teladoc Health Acquires Telecare, Expanding Access to Specialist and Allied Health Care for Australians in Public and Private Health - Yahoo Finance
Teladoc Health, Inc. shares fall 3.23% intraday as broader market sentiment dampens. - AInvest
Virtual Health Service Market Future Business Opportunities - openPR.com
Global Digital Therapeutics Market Experiencing Rapid Growth at a CAGR of ~28% by 2032 Amid Rising Demand for Personalized Healthcare| DelveInsight - The Malaysian Reserve
Hims & Hers Stock Plunges 21.3% in 3 Months: Time to Hold or Exit? - TradingView
2 Stocks Down More Than 90% That Still Aren't Worth Buying - AOL.com
Teladoc Health Reports Second Quarter 2025 Results - ADVFN Brasil
Teladoc Health Inc. Hits Oversold Level on RSI IndicatorReal Time Alerts Based on AI Prediction Triggered - 선데이타임즈
Global Digital Health Market Poised for Robust Growth at a CAGR of ~18% by 2032 Amid Rising Demand for Remote Care| DelveInsight - PR Newswire UK
Hims & Hers Drives the Consumer-Centric Transformation in Digital Care - TradingView
Teladoc's Strategic Shift: Can Integrated Care and Insurance-Driven Mental Health Restore Growth? - AInvest
Digital health Q2 earnings: New guys win, GLP-1 companies lose - Modern Healthcare
5 Must-Read Analyst Questions From Teladoc’s Q2 Earnings Call - Yahoo Finance
TDOC Q2 Deep Dive: Insurance Transition and Product Expansion Shape Outlook - ca.finance.yahoo.com
Global and U.S. AI-powered Telemedicine Market Exclusive - openPR.com
Price Channel Expanding on Teladoc Health Inc.’s ChartBuy Low Sell High Stock Watch Strategy in Focus - metal.it
Teladoc (TDOC) Q2 Revenue Tops Estimates - AOL.com
Teladoc Health, Inc. shares fall 1.65% intraday as healthcare sector faces broad challenges. - AInvest
Telemedicine Technologies Market Size Growth Trends Report 2035 - MarketReports.us
Revolutionizing Success in the Combined Telehealth - openPR.com
Hinge Health's Post-IPO Surge: A Test of Fundamentals in the Digital Therapeutics Gold Rush - AInvest
Amwell's Strategic Reinvention: Can Narrowing EBITDA Losses and Subscription Growth Fuel Long-Term Value in the Mental Health Tech Sector? - AInvest
Unexpected Trends Reshaping the U.S. Telemedicine Market - openPR.com
How the U.S. Telehealth Market Will Evolve by 2032Growth, - openPR.com
Global Telemedicine Market: Unxpected Growth in Digital Healthcare Delivery & Remote Care | 2025-2032 - openPR.com
Global Telehealth Market: Evolving Patient-Centric Platforms Driving Healthcare Transformation | 2025-2032 - openPR.com
Does Teladoc Health Inc. stock perform well during market downturnsHarness the power of proven investment plans - Jammu Links News
What are the technical indicators suggesting about Teladoc Health Inc.Build wealth faster with consistent investment plans - Jammu Links News
Teladoc Health Inc Stock (TDOC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.72%
0.81%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):